Axiota Animal Health
Overview
Axiota Animal Health is an innovation-driven company specializing in the development and marketing of products for beef and dairy producers worldwide. Established in 2020, Axiota has become a leading player in the animal health industry by offering biology-based, non-antibiotic solutions designed to help cattle thrive during transition and stress. The company is headquartered in Fort Collins, Colorado, and is headed by CEO Jon Lowe, with financial backing from Paine Schwartz Partners.
Recent Developments
- October 22, 2024: Axiota announced that its flagship product, Multimin® 90, received OMRI certification, expanding its use in organic cattle operations. This certification indicates adherence to organic production standards, enhancing the product's marketability to organic cattle farms.
- July 2024: The company issued new hires and promotions across three divisions to support its business growth. Key hires included Gene Gengelbach as the dairy technical services manager, Braden Troyer as feedlot technical services manager, and Favian Garcia as a technical sales representative.
- March 15, 2024: Axiota closed a Series C funding round, raising $30.1 million. This funding aims to support the expansion of its operational capabilities and product development initiatives.
- 2023: Axiota continued its expansion efforts, particularly in the dairy sector, by appointing Rodrigo Carranza as director of U.S. dairy sales, leveraging his extensive industry experience from companies like Zoetis and Cargill.
- 2022: Entered a notable partnership with Resilient Biotics to co-develop new technology for Bovine Respiratory Disease (BRD), intending to reduce antibiotic dependency by providing microbiome-based solutions.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2020 |
| Headquarters | Fort Collins, Colorado, United States |
| Founders | Jon Lowe |
| Revenue | Confidential |
| Profits | Confidential |
| Key Investors | Paine Schwartz Partners, Rabo Investments |
| Industry | Animal Health and Nutrition |
| Number of Employees | Approximately 80 |
Early History
Axiota Animal Health was founded in 2020 as a strategic initiative by Paine Schwartz Partners, a private equity firm known for its focus on sustainable food and agribusiness investments. The company emerged by unifying two established entities, Multimin USA and MS Biotec, which had a strong track record of providing trace mineral and microbial solutions to the cattle industry. Axiota quickly positioned itself to meet the growing demand for non-antibiotic solutions by leveraging the complementary strengths of these two brands.
Company Profile and Achievements
Axiota Animal Health operates primarily within the biotechnology and animal health sectors, focusing on providing scientifically validated products to enhance cattle health and productivity. Its core offerings include Multimin® 90 and Lactipro®:
- Multimin® 90: A prescription trace mineral injection that supports immune and reproductive health in cattle by providing essential minerals like zinc, selenium, copper, and manganese. This product is designed to optimize cattle health during critical production stages.
- Lactipro®: A rumen-focused microbial product featuring a live strain of Megasphaera elsdenii, which aids in maintaining rumen health during diet transition by metabolizing lactic acid. Axiota's notable achievements include successfully expanding its market reach across North America and its strategic partnership with Resilient Biotics to advance BRD technology. The firm has distinguished itself by focusing on sustainability and non-antibiotic solutions, aligning with consumer and regulatory trends towards more responsible livestock management.
Current Operations and Market Position
Axiota Animal Health is positioned as a leader in developing health solutions that enable cattle to thrive during stress and transition periods. The company focuses on integrating innovation with practical applications through its two main platforms: trace mineral supplementation and anaerobic microbial fermentation. Axiota continues to grow its market presence by extending its product offerings and enhancing its distribution network. Its competitive edge lies in its commitment to scientifically backed products and its deep understanding of industry needs, supported by an experienced team of animal health experts.
Conclusion
Axiota Animal Health plays a pivotal role in the animal health industry by delivering innovative, non-antibiotic solutions to support cattle health and productivity. The company's strategic focus on sustainable products aligns with shifting consumer preferences and industry trends, positioning it for continued success and expansion. With ongoing investments in product development and strategic partnerships, Axiota is poised to capitalize on future opportunities and drive innovation in cattle health management.